This trial is testing if a combination of methylphenidate (a type of central nervous system stimulant) and exercise can reduce cancer-related fatigue in patients with prostate cancer.
1 Primary · 1 Secondary · Reporting Duration: Up to 12 weeks
Active Control
Experimental Treatment
354 Total Participants · 4 Treatment Groups
Primary Treatment: Exercise Intervention · Has Placebo Group · Phase 2 & 3
Age 18+ · Male Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: